FENAZIL POM 15G 2%

FENAZIL

active ingredients

FENAZIL 2% cream 100 g contain: Active ingredient: Prometazine hydrochloride 2,00 g. Excipients with known effects: Parahydroxybenzoate. FENAZIL 2% cutaneous pencil 100 g contain: Active ingredient: Prometazine hydrochloride 2,00 g. Excipients with known effects: Propylene glycol, cetilic alcohol and stearic acid. For the full list of excipients see paragraph 6.1.

Excellent

FENAZIL 2% glycerol cream, polyethylene-lic ester of fatty acids, stearic acid, lavender fragrant essence, methyl parahydroxybenzoate, purified water. FENAZIL 2% cutaneous pencil Stearic acid, cetilic alcohol, ethylene glycol, propylene glycol, lavender essence, ethyl alcohol.

Therapeutic indications

Temporary use in case of insect bites and other localized skin irritative phenomena, such as redness, burning and itching.

Contraindications

Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1. In case of eczema or secretive injuries. Contraindicated in children under 2 years of age.

Population

Fenazil Skin Pencil Fry slightly and for a few seconds the Fenazil cutaneous pencil on the affected part, 3 – 4 times a day. Fenazil cream Apply a slight layer of Fenazil cream on the affected part, massaging until full penetration. Repeat application 3 – 4 times a day. Do not exceed the recommended doses.

Conservation

Store at temperature not exceeding 30 ° C.

Warnings

The medicine is only for external use. Do not use for prolonged treatments. Prolonged and incongruous use of the medicinal product can give rise to allergic sensitization phenomena, resulting in worsening of symptomatology. If this happens, the treatment must be suspended in order to establish suitable therapy. Since the application of Fenazil can delay the healing process, it should not be used for more than 3 – 4 consecutive days on injuries in which this phenomenon is taking place. In the case of solar erythema, do not expose the part, after application, to the sun. If skin rashes occur, irritation phenomena and burning the treatment must be suspended. Fenazil cream Apply the cream with precaution and thin layer when the skin has very extensive abrasions, to avoid a systemic absorption of the medicinal product. The too abundant application of cream on very extensive areas of the skin can determine the absorption of the drug and cause, in particularly sensitive patients, drowsiness. Fenazil Skin Pencil Use only on integral skin. Avoid contact of the Fenazil cutaneous pencil with mucosa, genital parts and wounds. Wash your hands with soap and water after use and close the container well. Important information about some Fenazil cream excipients contains: – parahydroxybenzoate methyl therefore can cause allergic reactions (also delayed) – polyethyleneglic ester of fatty acids which can cause skin irritation. Fenazil Skin Pencil contains: – propylene glycol therefore can cause skin irritation – cetilic alcohol and stearic acid, which can cause local skin reactions (e.g. contact dermatitis).

Interactions

Avoid the contemporary use of other medications for skin use.

Effects

The topical application of promethazine may, in some cases, induce skin sensitization to forms of photosensitization. The use, especially if prolonged, of medicinal products for skin use can give rise to phenomena of sensitization: in this case, stop the treatment and consult the doctor, to establish suitable therapy. Reporting of suspicious adverse reactions. The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address www.agenziafarmaco.gov.it/it/responsabili.

Overdosing

If accidentally ingested in significant quantities, the product may initially cause excitement in children, while in the adult it initially predominates drowsiness. There are no specific antidotes: the therapy is symptomatic (gastric lavanda).

There are no restrictions on use during pregnancy and nursing. It is, however, recommended to use only after consulting a doctor.

Source: Farmadati